Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A novel TRMT5 mutation causes a complex inherited neuropathy syndrome: The role of nerve pathology in defining a demyelinating neuropathy

  • Argente-Escrig, Herminia
  • Vílchez, Juan Jesús
  • Frasquet, Marina
  • Muelas, Nuria
  • Azorín, Inmaculada
  • Vílchez, Roger
  • Millet-Sancho, Elvira
  • Pitarch, Inmaculada
  • Tomás-Vila, Miguel
  • Vazquez-Costa, Juan F.
  • Mas-Estellés, Fernando
  • Marco-Marín, Clara
  • Espinós, Carmen
  • Serrano-Lorenzo, Pablo
  • Martín, Miguel A.
  • Lupo, Vincenzo
  • Sevilla, Teresa
14 páginas, 4 figuras, 3 tablas, Aims: We aim to present data obtained from three patients belonging to three unrelated families with an infantile onset demyelinating neuropathy associated to somatic and neurodevelopmental delay and to describe the underlying genetic changes. Methods: We performed whole-exome sequencing on genomic DNA from the patients and their parents and reviewed the clinical, muscle and nerve data, the serial neurophysiological studies, brain and muscle MRIs, as well as the respiratory chain complex activity in the muscle of the three index patients. Computer modelling was used to characterise the new missense variant detected. Results: All three patients had a short stature, delayed motor milestone acquisition, intellectual disability and cerebellar abnormalities associated with a severe demyelinating neuropathy, with distinct morphological features. Despite the proliferation of giant mitochondria, the mitochondrial respiratory chain complex activity in skeletal muscle was normal, except in one patient in whom there was a mild decrease in complex I enzyme activity. All three patients carried the same two compound heterozygous variants of the TRMT5 (tRNA Methyltransferase 5) gene, one known pathogenic frameshift mutation [c.312_315del (p.Ile105Serfs*4)] and a second rare missense change [c.665 T > C (p.Ile222Thr)]. TRMT5 is a nuclear-encoded protein involved in the post-transcriptional maturation of mitochondrial tRNA. Computer modelling of the human TRMT5 protein structure suggests that the rare p.Ile222Thr mutation could affect the stability of tRNA binding. Conclusions: Our study expands the phenotype of mitochondrial disorders caused by TRTM5 mutations and defines a new form of recessive demyelinating peripheral neuropathy., Fundación Isabel Gemio; Generalitat Valenciana, Grant/Award Number:PROMETEO/2018/13; Fondo Europeo deDesarrollo Regional (FEDER); Instituto deSalud Carlos III, Grant/Award Numbers:PI19/01178, PI18/01374, PI16/00403, Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Multicentric standardization of protocols for the diagnosis of human mitochondrial respiratory chain defects

  • Bujan, N.
  • Morén, C.
  • García-García, F. J.
  • Blázquez, A.
  • Carnicer, C.
  • Cortés, A. B.
  • González, C.
  • López-Gallardo, E.
  • Lozano, E.
  • Moliner, S.
  • Gort, L.
  • Tobías, E.
  • Delmiro, A.
  • Martin, M. Á.
  • Fernández-Moreno, M. Á.
  • Ruiz-Pesini, E.
  • Garcia-Arumí, E.
  • Rodríguez-Aguilera, J. C.
  • Garrabou, G.
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The genetic landscape of mitochondrial diseases in Spain: A nationwide call

  • Bellusci, M.
  • Paredes-Fuentes, A.J.
  • Ruiz-Pesini, E.
  • Gómez, B.
  • Martín, M.A.
  • Montoya, J.
  • Artuch, R.
  • MITOSPAIN Working Group
  • Emperador Ortiz, Sonia
The frequency of mitochondrial diseases (MD) has been scarcely documented, and only a few studies have reported data in certain specific geographical areas. In this study, we arranged a nationwide call in Spain to obtain a global estimate of the number of cases. A total of 3274 cases from 49 Spanish provinces were reported by 39 centres. Excluding duplicated and unsolved cases, 2761 patients harbouring pathogenic mutations in 140 genes were recruited between 1990 and 2020. A total of 508 patients exhibited mutations in nuclear DNA genes (75% paediatric patients) and 1105 in mitochondrial DNA genes (33% paediatric patients). A further 1148 cases harboured mutations in the MT-RNR1 gene (56% paediatric patients). The number of reported cases secondary to nuclear DNA mutations increased in 2014, owing to the implementation of next-generation sequencing technologies. Between 2014 and 2020, excepting MT-RNR1 cases, the incidence was 6.34 (95% CI: 5.71–6.97) cases per million inhabitants at the paediatric age and 1.36 (95% CI: 1.22–1.50) for adults. In conclusion, this is the first study to report nationwide epidemiological data for MD in Spain. The lack of identification of a remarkable number of mitochondrial genes necessitates the systematic application of high-throughput technologies in the routine diagnosis of MD. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis

  • Domínguez-González, Cristina|||0000-0001-5151-988X
  • Fernández-Torrón, Roberto
  • Moore, Ursula|||0000-0002-0643-5596
  • de Fuenmayor-Fernández de la Hoz, Carlos Pablo
  • Vélez-Gómez, Beatriz|||0000-0001-5796-5872
  • Cabezas, Juan Antonio
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • González Mera, Laura
  • Olivé i Plana, Montserrat|||0000-0001-5727-0165
  • García-García, Jorge
  • Morís, Germán|||0000-0001-7608-2194
  • León Hernández, Juan Carlos
  • Muelas, Nuria|||0000-0002-2349-7481
  • Servian-Morilla, Emilia
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Paradas, Carmen|||0000-0002-6917-2236
Background and objective: TK2 deficiency (TK2d) is a rare mitochondrial disorder that manifests predominantly as a progressive myopathy with a broad spectrum of severity and age of onset. The rate of progression is variable, and the prognosis is poor due to early and severe respiratory involvement. Early and accurate diagnosis is particularly important since a specific treatment is under development. This study aims to evaluate the diagnostic value of lower limb muscle MRI in adult patients with TK2d. Methods: We studied a cohort of 45 genetically confirmed patients with mitochondrial myopathy (16 with mutations in TK2, 9 with mutations in other nuclear genes involved in mitochondrial DNA [mtDNA] synthesis or maintenance, 10 with single mtDNA deletions, and 10 with point mtDNA mutations) to analyze the imaging pattern of fat replacement in lower limb muscles. We compared the identified pattern in patients with TK2d with the MRI pattern of other non-mitochondrial genetic myopathies that share similar clinical characteristics. Results: We found a consistent lower limb muscle MRI pattern in patients with TK2d characterized by involvement of the gluteus maximus, gastrocnemius medialis, and sartorius muscles. The identified pattern in TK2 patients differs from the known radiological involvement of other resembling muscle dystrophies that share clinical features. Conclusions: By analyzing the largest cohort of muscle MRI from patients with mitochondrial myopathies studied to date, we identified a characteristic and specific radiological pattern of muscle involvement in patients with TK2d that could be useful to speed up its diagnosis.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects

  • Bujan, Nuria
  • Morén, Constanza|||0000-0001-6848-7407
  • García García, Francesc Josep|||0000-0001-9021-0324
  • Blázquez, Alberto|||0000-0002-6479-3615
  • Carnicer, Clara
  • Cortés Rodríguez, Ana Belén|||0000-0003-0675-6485
  • González, Cristina
  • López-Gallardo, Ester
  • Lozano, Ester|||0000-0002-6307-9807
  • Moliner, Sonia
  • Gort, Laura|||0000-0003-4746-1034
  • Tobías, Ester|||0000-0002-9968-3651
  • Delmiro, Aitor
  • Martín, Miguel A.|||0000-0003-4741-772X
  • Fernández-Moreno, Miguel Ángel|||0000-0002-3461-0726
  • Ruiz-Pesini, Eduardo|||0000-0002-0269-7337
  • García Arumí, Elena|||0000-0003-1848-005X
  • Rodríguez Aguilera, Juan Carlos|||0000-0002-3371-4128
  • Garrabou, Glòria|||0000-0001-8973-9933
The quantification of mitochondrial respiratory chain (MRC) enzymatic activities is essential for diagnosis of a wide range of mitochondrial diseases, ranging from inherited defects to secondary dysfunctions. MRC lesion is frequently linked to extended cell damage through the generation of proton leak or oxidative stress, threatening organ viability and patient health. However, the intrinsic challenge of a methodological setup and the high variability in measuring MRC enzymatic activities represents a major obstacle for comparative analysis amongst institutions. To improve experimental and statistical robustness, seven Spanish centers with extensive experience in mitochondrial research and diagnosis joined to standardize common protocols for spectrophotometric MRC enzymatic measurements using minimum amounts of sample. Herein, we present the detailed protocols, reference ranges, tips and troubleshooting methods for experimental and analytical setups in different sample preparations and tissues that will allow an international standardization of common protocols for the diagnosis of MRC defects. Methodological standardization is a crucial step to obtain comparable reference ranges and international standards for laboratory assays to set the path for further diagnosis and research in the field of mitochondrial diseases.